Dr. Carlos A. Tristan, Ph.D., M.S., serves as the director of the Stem Cell Translation Laboratory (SCTL)
within NCATS’ Division of Preclinical Innovation. Dr. Tristan's work revolves around leveraging multi-omic technologies to develop and optimize protocols for maintaining and differentiating human pluripotent stem cells (hPSCs), thereby accelerating the translational application of hPSC-derived cells in disease modeling, regenerative therapy and drug discovery. He joined SCTL in 2016, assuming the role of staff scientist, where he focused on establishing chemical, robotic, high-throughput and multi-omic platforms to address current challenges in the hPSC field. Prior to his tenure at NCATS, Dr. Tristan conducted postdoctoral research at the National Cancer Institute’s Center for Cancer Research in Bethesda, Maryland, delving into the molecular mechanisms of tumor-initiating cells in glioblastoma multiforme. He earned his Ph.D. in cellular and molecular medicine from the Johns Hopkins University School of Medicine, where his research in the Department of Psychiatry and Behavioral Sciences uncovered novel signaling mechanisms and crosstalk among cell stress-signaling cascades. Dr. Tristan holds an M.S. in biology, as well as two Bachelor’s degrees in chemistry and biology, all from the California State University, Fresno.
Dr. Carlos A. Tristan, Ph.D., M.S., serves as the director of the Stem Cell Translation Laboratory (SCTL)
within NCATS’ Division of Preclinical Innovation. Dr. Tristan's work revolves around leveraging multi-omic technologies to develop and optimize protocols for maintaining and differentiating human pluripotent stem cells (hPSCs), thereby accelerating the translational application of hPSC-derived cells in disease modeling, regenerative therapy and drug discovery. He joined SCTL in 2016, assuming the role of staff scientist, where he focused on establishing chemical, robotic, high-throughput and multi-omic platforms to address current challenges in the hPSC field. Prior to his tenure at NCATS, Dr. Tristan conducted postdoctoral research at the National Cancer Institute’s Center for Cancer Research in Bethesda, Maryland, delving into the molecular mechanisms of tumor-initiating cells in glioblastoma multiforme. He earned his Ph.D. in cellular and molecular medicine from the Johns Hopkins University School of Medicine, where his research in the Department of Psychiatry and Behavioral Sciences uncovered novel signaling mechanisms and crosstalk among cell stress-signaling cascades. Dr. Tristan holds an M.S. in biology, as well as two Bachelor’s degrees in chemistry and biology, all from the California State University, Fresno.